Home
PHAT
PHAT News

Latest Phathom Pharmaceuticals Inc. (PHAT) News on July 12, 2025

Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

18 days ago

Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Phathom Pharmaceuticals Appoints Anne Marie Cook as Chief Legal Officer and Corporate Secretary

GlobeNewswire

19 days ago

Phathom Pharmaceuticals Appoints Anne Marie Cook as Chief Legal Officer and Corporate Secretary

MT Newswires

a month ago

Phathom Pharmaceuticals' Heartburn Drug Receives Regulatory Exclusivity in FDA Orange Book Update

Phathom Pharmaceuticals Announces FDA Correction to Orange Book Listing, Confirming 10 Years of Regulatory Exclusivity for VOQUEZNA® (vonoprazan) Tablets Through May 3, 2032

GlobeNewswire

a month ago

Phathom Pharmaceuticals Announces FDA Correction to Orange Book Listing, Confirming 10 Years of Regulatory Exclusivity for VOQUEZNA® (vonoprazan) Tablets Through May 3, 2032

Wall Street Analysts Believe Phathom Pharmaceuticals (PHAT) Could Rally 107.4%: Here's is How to Trade

Zacks

a month ago

Wall Street Analysts Believe Phathom Pharmaceuticals (PHAT) Could Rally 107.4%: Here's is How to Trade

MT Newswires

a month ago

Sector Update: Health Care Stocks Rise Late Afternoon

MT Newswires

a month ago

Top Midday Gainers

MT Newswires

a month ago

Sector Update: Health Care Stocks Advance in Afternoon Trading

MT Newswires

a month ago

Sector Update: Health Care

MT Newswires

a month ago

Phathom Pharmaceuticals Shares Surge After FDA Grants 10-Year Exclusivity for Acid-Reducing Drug

Investing.com

a month ago

Phathom Pharmaceuticals shares soar on FDA exclusivity grant

Phathom Pharmaceuticals Announces Positive FDA Decision to Recognize 10 Years of Regulatory Exclusivity for VOQUEZNA® (vonoprazan) Tablets through May 3, 2032

GlobeNewswire

a month ago

Phathom Pharmaceuticals Announces Positive FDA Decision to Recognize 10 Years of Regulatory Exclusivity for VOQUEZNA® (vonoprazan) Tablets through May 3, 2032

Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences

GlobeNewswire

2 months ago

Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences

After Plunging -45.82% in 4 Weeks, Here's Why the Trend Might Reverse for Phathom Pharmaceuticals (PHAT)

Zacks

2 months ago

After Plunging -45.82% in 4 Weeks, Here's Why the Trend Might Reverse for Phathom Pharmaceuticals (PHAT)

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Just Reported, And Analysts Assigned A US$18.63 Price Target

Simply Wall St.

2 months ago

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Just Reported, And Analysts Assigned A US$18.63 Price Target

Phathom Pharmaceuticals First Quarter 2025 Earnings: Misses Expectations

Simply Wall St.

2 months ago

Phathom Pharmaceuticals First Quarter 2025 Earnings: Misses Expectations

Phathom Pharmaceuticals Inc (PHAT) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid ...

GuruFocus.com

2 months ago

Phathom Pharmaceuticals Inc (PHAT) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid ...

Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

2 months ago

Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Phathom Pharmaceuticals, Inc. (PHAT) Reports Q1 Loss, Tops Revenue Estimates

Zacks

2 months ago

Phathom Pharmaceuticals, Inc. (PHAT) Reports Q1 Loss, Tops Revenue Estimates

Phathom Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire

2 months ago

Phathom Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

Phathom Pharmaceuticals to Present VOQUEZNA® (vonoprazan) Data at DDW 2025 Annual Meeting

GlobeNewswire

2 months ago

Phathom Pharmaceuticals to Present VOQUEZNA® (vonoprazan) Data at DDW 2025 Annual Meeting

Phathom Pharmaceuticals to Report First Quarter 2025 Financial Results and Provide Business Update on Thursday, May 1, 2025

GlobeNewswire

3 months ago

Phathom Pharmaceuticals to Report First Quarter 2025 Financial Results and Provide Business Update on Thursday, May 1, 2025

Phathom Pharmaceuticals (NASDAQ:PHAT) shareholders have endured a 87% loss from investing in the stock five years ago

Simply Wall St.

3 months ago

Phathom Pharmaceuticals (NASDAQ:PHAT) shareholders have endured a 87% loss from investing in the stock five years ago

Phathom Pharmaceuticals Appoints Ted Schroeder to its Board of Directors

GlobeNewswire

3 months ago

Phathom Pharmaceuticals Appoints Ted Schroeder to its Board of Directors

Rhythm Pharmaceuticals (RYTM) Surges 17.1%: Is This an Indication of Further Gains?

Zacks

3 months ago

Rhythm Pharmaceuticals (RYTM) Surges 17.1%: Is This an Indication of Further Gains?

Phathom Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference

GlobeNewswire

3 months ago

Phathom Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference

Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

3 months ago

Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MT Newswires

3 months ago

Phathom Pharmaceuticals Names Steven Basta CEO

Phathom Pharmaceuticals Announces Leadership Succession

GlobeNewswire

3 months ago

Phathom Pharmaceuticals Announces Leadership Succession

Actor and Comedian Kenan Thompson Teams Up with Phathom Pharmaceuticals to Raise Awareness About GERD and VOQUEZNA® (vonoprazan)

GlobeNewswire

3 months ago

Actor and Comedian Kenan Thompson Teams Up with Phathom Pharmaceuticals to Raise Awareness About GERD and VOQUEZNA® (vonoprazan)

MT Newswires

4 months ago

Jefferies Cuts Price Target on Phathom Pharmaceuticals to $13 From $17, Maintains Buy Rating

Phathom Pharmaceuticals Full Year 2024 Earnings: Beats Expectations

Simply Wall St.

4 months ago

Phathom Pharmaceuticals Full Year 2024 Earnings: Beats Expectations

Phathom Pharmaceuticals Inc (PHAT) Q4 2024 Earnings Call Highlights: FDA Approval Boosts ...

GuruFocus.com

4 months ago

Phathom Pharmaceuticals Inc (PHAT) Q4 2024 Earnings Call Highlights: FDA Approval Boosts ...

Phathom Pharmaceuticals, Inc. (PHAT) Reports Q4 Loss, Tops Revenue Estimates

Zacks

4 months ago

Phathom Pharmaceuticals, Inc. (PHAT) Reports Q4 Loss, Tops Revenue Estimates

Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

GlobeNewswire

4 months ago

Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Earnings To Watch: Phathom Pharmaceuticals Inc (PHAT) Reports Q4 2024 Result

GuruFocus.com

4 months ago

Earnings To Watch: Phathom Pharmaceuticals Inc (PHAT) Reports Q4 2024 Result

Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update on Thursday, March 6, 2025

GlobeNewswire

5 months ago

Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update on Thursday, March 6, 2025

MT Newswires

5 months ago

Cantor Fitzgerald Initiates Coverage on Phathom Pharmaceuticals With Overweight Rating, $23 Price Target

Phathom Pharmaceuticals to Present at the Guggenheim Securities SMID Cap Biotech Conference

GlobeNewswire

5 months ago

Phathom Pharmaceuticals to Present at the Guggenheim Securities SMID Cap Biotech Conference

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT): Are Analysts Optimistic?

Simply Wall St.

6 months ago

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT): Are Analysts Optimistic?

Do You Believe in the Growth Potential of Phathom Pharmaceuticals (PHAT)?

Insider Monkey

7 months ago

Do You Believe in the Growth Potential of Phathom Pharmaceuticals (PHAT)?

MT Newswires

7 months ago

Phathom Pharmaceuticals Files US FDA Petition to Seek Voquezna Exclusivity Period

Phathom Pharmaceuticals Submits Citizen Petition to FDA Seeking Correction of Orange Book Listings for VOQUEZNA® (vonoprazan) Tablets

GlobeNewswire

7 months ago

Phathom Pharmaceuticals Submits Citizen Petition to FDA Seeking Correction of Orange Book Listings for VOQUEZNA® (vonoprazan) Tablets

Down -54.05% in 4 Weeks, Here's Why Phathom Pharmaceuticals (PHAT) Looks Ripe for a Turnaround

Zacks

7 months ago

Down -54.05% in 4 Weeks, Here's Why Phathom Pharmaceuticals (PHAT) Looks Ripe for a Turnaround

Phathom Pharmaceuticals (PHAT) Upgraded to Buy: Here's What You Should Know

Zacks

8 months ago

Phathom Pharmaceuticals (PHAT) Upgraded to Buy: Here's What You Should Know

Phathom Pharmaceuticals Inc (PHAT) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ...

GuruFocus.com

8 months ago

Phathom Pharmaceuticals Inc (PHAT) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ...

MT Newswires

8 months ago

Phathom Pharmaceuticals Shares Fall After Q3 Loss Widens

Phathom Pharmaceuticals, Inc. (PHAT) Reports Q3 Loss, Tops Revenue Estimates

Zacks

8 months ago

Phathom Pharmaceuticals, Inc. (PHAT) Reports Q3 Loss, Tops Revenue Estimates

Phathom Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Updates

GlobeNewswire

8 months ago

Phathom Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Updates

Phathom Pharmaceuticals Inc (PHAT) Q3 2024 Earnings Report Preview: What to Look For

GuruFocus.com

8 months ago

Phathom Pharmaceuticals Inc (PHAT) Q3 2024 Earnings Report Preview: What to Look For

Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences

GlobeNewswire

8 months ago

Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences

Investors bid Phathom Pharmaceuticals (NASDAQ:PHAT) up US$75m despite increasing losses YoY, taking one-year return to 96%

Simply Wall St.

8 months ago

Investors bid Phathom Pharmaceuticals (NASDAQ:PHAT) up US$75m despite increasing losses YoY, taking one-year return to 96%

Phathom Pharmaceuticals to Report Third Quarter 2024 Financial Results and Provide Business Update on Thursday, November 7, 2024

GlobeNewswire

8 months ago

Phathom Pharmaceuticals to Report Third Quarter 2024 Financial Results and Provide Business Update on Thursday, November 7, 2024

Phathom Pharmaceuticals to Present VOQUEZNA® Data at the American College of Gastroenterology (ACG) 2024 Annual Meeting

GlobeNewswire

8 months ago

Phathom Pharmaceuticals to Present VOQUEZNA® Data at the American College of Gastroenterology (ACG) 2024 Annual Meeting

Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences

GlobeNewswire

10 months ago

Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences

MT Newswires

a year ago

Phathom Pharmaceuticals Prices Underwritten Offering of Shares and Warrants

Phathom Pharmaceuticals Announces Pricing of $130 Million Offering of Common Stock and Pre-Funded Warrants

GlobeNewswire

a year ago

Phathom Pharmaceuticals Announces Pricing of $130 Million Offering of Common Stock and Pre-Funded Warrants

Phathom Pharmaceuticals, Inc. (PHAT) Reports Q2 Loss, Tops Revenue Estimates

Zacks

a year ago

Phathom Pharmaceuticals, Inc. (PHAT) Reports Q2 Loss, Tops Revenue Estimates

Phathom Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire

a year ago

Phathom Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update

Phathom Pharmaceuticals Announces VOQUEZNA® (vonoprazan) Added to CVS Caremark Formularies for Commercially Insured Patients

GlobeNewswire

a year ago

Phathom Pharmaceuticals Announces VOQUEZNA® (vonoprazan) Added to CVS Caremark Formularies for Commercially Insured Patients

Phathom Pharmaceuticals to Report Second Quarter 2024 Financial Results and Provide Business Update on Thursday, August 8, 2024

GlobeNewswire

a year ago

Phathom Pharmaceuticals to Report Second Quarter 2024 Financial Results and Provide Business Update on Thursday, August 8, 2024

MT Newswires

a year ago

Phathom Pharmaceuticals Gets New FDA Approval for Voquezna Tablets

Argus Research

a year ago

Daily – Vickers Top Buyers & Sellers for 07/18/2024

Phathom Pharmaceuticals Announces FDA Approval of VOQUEZNA® (vonoprazan) Tablets for the Relief of Heartburn Associated with Non-Erosive GERD in Adults

GlobeNewswire

a year ago

Phathom Pharmaceuticals Announces FDA Approval of VOQUEZNA® (vonoprazan) Tablets for the Relief of Heartburn Associated with Non-Erosive GERD in Adults

Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences

GlobeNewswire

a year ago

Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences

Phathom Pharmaceuticals to Present VOQUEZNA® (vonoprazan) Data at DDW 2024 Annual Meeting

GlobeNewswire

a year ago

Phathom Pharmaceuticals to Present VOQUEZNA® (vonoprazan) Data at DDW 2024 Annual Meeting

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Q1 2024 Earnings Call Transcript

Insider Monkey

a year ago

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Q1 2024 Earnings Call Transcript

Phathom Pharmaceuticals, Inc. (PHAT) Reports Q1 Loss, Lags Revenue Estimates

Zacks

a year ago

Phathom Pharmaceuticals, Inc. (PHAT) Reports Q1 Loss, Lags Revenue Estimates

Phathom Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire

a year ago

Phathom Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update

MT Newswires

a year ago

Stifel Starts Phathom Pharmaceuticals With Buy Rating, $24 Price Target

Phathom Pharmaceuticals to Report First Quarter 2024 Financial Results and Provide Business Update on Thursday, May 9, 2024

GlobeNewswire

a year ago

Phathom Pharmaceuticals to Report First Quarter 2024 Financial Results and Provide Business Update on Thursday, May 9, 2024

MasterCraft Boat, SentinelOne, and More Stocks See Action From Activist Investors

Barrons.com

a year ago

MasterCraft Boat, SentinelOne, and More Stocks See Action From Activist Investors

12 Most Shorted Stocks in 2024

Insider Monkey

a year ago

12 Most Shorted Stocks in 2024

ARS Pharmaceuticals, Nuvalent, and More Stocks See Action From Activist Investors

Barrons.com

a year ago

ARS Pharmaceuticals, Nuvalent, and More Stocks See Action From Activist Investors

Phathom Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference

GlobeNewswire

a year ago

Phathom Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Phathom Pharmaceuticals Launches Direct-to-Consumer Campaign, “VOQUEZNA Can Kick Some Acid”

GlobeNewswire

a year ago

Phathom Pharmaceuticals Launches Direct-to-Consumer Campaign, “VOQUEZNA Can Kick Some Acid”

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Q4 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

a year ago

Q4 2023 Phathom Pharmaceuticals Inc Earnings Call

Phathom Pharmaceuticals Inc (PHAT) Reports Q4 and Full Year 2023 Financials, Eyes Growth with ...

GuruFocus.com

a year ago

Phathom Pharmaceuticals Inc (PHAT) Reports Q4 and Full Year 2023 Financials, Eyes Growth with ...

Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

GlobeNewswire

a year ago

Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 7, 2024

GlobeNewswire

a year ago

Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 7, 2024

Phathom Pharmaceuticals Announces VOQUEZNA® (vonoprazan) Tablets for Erosive GERD and Associated Heartburn Added to Express Scripts National Formularies for Commercial Patients

GlobeNewswire

a year ago

Phathom Pharmaceuticals Announces VOQUEZNA® (vonoprazan) Tablets for Erosive GERD and Associated Heartburn Added to Express Scripts National Formularies for Commercial Patients

Hawaiian Holdings, Inc. (NASDAQ:HA) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

Hawaiian Holdings, Inc. (NASDAQ:HA) Q4 2023 Earnings Call Transcript

10 Highest Quality Egg Brands in the US

Insider Monkey

a year ago

10 Highest Quality Egg Brands in the US

Denny's shutters only location in Oakland after more than 54 years due to high crime

Fox Business

a year ago

Denny's shutters only location in Oakland after more than 54 years due to high crime

Hawaiian Holdings (HA) Reports Wider-Than-Expected Loss in Q4

Zacks

a year ago

Hawaiian Holdings (HA) Reports Wider-Than-Expected Loss in Q4

Phathom Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

GlobeNewswire

a year ago

Phathom Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

REGENXBIO Announces Presentations at the 20th Annual WORLDSymposium 2024

PR Newswire

a year ago

REGENXBIO Announces Presentations at the 20th Annual WORLDSymposium 2024

Coastal Financial Corporation Announces Fourth Quarter and Fiscal Year 2023 Results

GlobeNewswire

a year ago

Coastal Financial Corporation Announces Fourth Quarter and Fiscal Year 2023 Results

Garrett Motion (NASDAQ:GTX) investors are sitting on a loss of 46% if they invested five years ago

Simply Wall St.

a year ago

Garrett Motion (NASDAQ:GTX) investors are sitting on a loss of 46% if they invested five years ago

With 47% ownership, Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) has piqued the interest of institutional investors

Simply Wall St.

a year ago

With 47% ownership, Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) has piqued the interest of institutional investors

I Want To Add An Investment Property To My Retirement Portfolio. Should I Focus On Cash Flow Or Appreciation?

Benzinga

a year ago

I Want To Add An Investment Property To My Retirement Portfolio. Should I Focus On Cash Flow Or Appreciation?

Where Will Novavax Be in 5 Years?

Motley Fool

a year ago

Where Will Novavax Be in 5 Years?

Better Stock to Buy: Etsy vs. Beyond Meat

Motley Fool

a year ago

Better Stock to Buy: Etsy vs. Beyond Meat

Southside Bancshares (SBSI) Lags Q4 Earnings and Revenue Estimates

Zacks

a year ago

Southside Bancshares (SBSI) Lags Q4 Earnings and Revenue Estimates

LegalZoom to Announce Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 22, 2024

GlobeNewswire

a year ago

LegalZoom to Announce Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 22, 2024

Associated Press Finance

a year ago

Cass: Q4 Earnings Snapshot

Business Wire

a year ago

Cass Information Systems Reports Fourth Quarter 2023 Results

Business Wire

a year ago

Dorian LPG Ltd. Provides Update for Third Quarter 2024 and Announces Third Quarter 2024 Earnings and Conference Call Date

Resources Connection (NASDAQ:RGP) Will Pay A Dividend Of $0.14

Simply Wall St.

a year ago

Resources Connection (NASDAQ:RGP) Will Pay A Dividend Of $0.14

Share on Social Networks: